HomeProduct Newsletter Amino Acids China E-News

Amino Acids China E-News

Publication: Monthly on the
Published by CCM

Amino Acids China E-News provides you with real-time intelligence on China's amino acids market.
 
China has rapidly emerged as a leading producer of amino acids in recent years thanks to increasing demand from the country's feed and pharmaceuticals markets. However, competition in the industry is shifting as producers battle to upgrade their production technology to comply with strict new environmental regulations and create higher-margin pharmaceutical-grade products.
 
Amino Acids China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire amino acid industry chain, from raw materials to end consumption. This includes:
      
  • Breaking news from China and abroad
    •   
  • The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
    •   
  • In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
    •   
  • Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
Amino Acids China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.

www.cnchemicals.com www.cnchemicals.com

  • Future-issues subscription

Starting from the issue of
202404
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,950.00
  • Corporate license:
    USD 7,375.00

All the prices on this website exclude VAT.
<<
  • 202404
  • 202403
  • 202402
  • 202401
  • 202312
  • 202311
  • 202310
  • 202309
  • 202308
  • 202307
  • 202306
  • 202305
  • 202304
  • 202303
  • 202302
  • 202301
  • 202212
  • 202211
  • 202210
  • 202209
  • 202208
  • 202207
  • 202206
  • 202205
  • 202204
  • 202203
  • 202202
  • 202201
  • 202112
  • 202111
  • 202110
  • 202109
  • 202108
  • 202107
  • 202106
  • 202105
  • 202104
  • 202103
  • 202102
  • 202101
  • 202012
  • 202011
  • 202010
  • 202009
  • 202008
  • 202007
  • 202006
  • 202005
  • 202004
  • 202003
  • 202002
  • 202001
  • 201912
  • 201911
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201706
  • 201705
  • 201704
  • 201703
  • 201702
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
  • 201505
  • 201504
  • 201503
  • 201502
  • 201501
  • 201412
  • 201411
  • 201410
  • 201409
  • 201408
>>

Main Content of Amino Acids China E-News 202104

Price of this issue :
USD 123

Published on 30th April, 2021

On 16 April, Tianyao Pharmaceutical released its 2020 performance, showing that both of its revenues and profits decreased in 2020. It has been the company's first decline since 2017, with its net profits tumbling by 79%.

Published on 30th April, 2021

Published on 30th April, 2021

Published on 30th April, 2021

Published on 30th April, 2021

On 1 April, Global Bio-chem Technology published its annual report for 2020, showing that its revenues tumbled by 81.4% while its net loss shot up by 118%. The poor performance was mainly attributed to price hikes of corn, suspension of its most production facilities as well as its debt restructuring.

Published on 30th April, 2021

In 2020, Zhejiang NHU recorded a new high in revenues benefited from rising prices and sales of its key products. Meanwhile, market shares of its methionine and other major products experienced sharp increases.

Published on 30th April, 2021

On 1 April, the Ministry of Industry and Information Technology of China made an announcement on its submitting of two industry standards of branched chain amino acids (L-leucine, L-isoleucine and L-valine) and L-glutamine for approvals. After they come into force, the two standards will regulate production of branched chain amino acids and glutamine industries as well as provide a sound legal basis for their production & sales, their exports and technological and economical exchanges.

Published on 30th April, 2021

Food grade L-methionylglycine&middot;HCl and &epsilon;-poly-L-lysine hydrochloride national standards open for comments On 26 March, China made its food grade L-methionylglycine&middot;HCl and &epsilon;-poly-L-lysine hydrochloride national standards open for comments with a deadline of 30 April.

Published on 30th April, 2021

Sealong Biotechnology and Jincheng Pharm published their performances for 2020 on 20 April and 27 April respectively. Sealong Biotechnology achieved growth in both revenues and profits, with its asparaginic acid revenue enjoying double-digit growth; while Jincheng Pharm suffered losses despite increasing revenue and profit from amino acid APIs of its subsidiary.

Published on 30th April, 2021

Published on 30th April, 2021

Published on 30th April, 2021

Due to tight supply, stronger demand from downstream and decreasing import volume, China's methionine price continued to rise in April, breaking a record since Jan. 2017.

Published on 30th April, 2021

China's methionine import volume decreased by 11.1% MoM and 32.7% MoM in Jan. and Feb. Meanwhile, its import price rose by 8.7% and 4.7% respectively, which may be the key reason for the decline in import volume.

Published on 30th April, 2021

Published on 30th April, 2021

Published on 30th April, 2021

Published on 28th April, 2021

Published on 28th April, 2021

Published on 28th April, 2021

Published on 28th April, 2021

Published on 28th April, 2021

On 31 March, Huaheng Biotech released its IPO letter of intent showing that the company is set to be listed on the Shanghai Stock Exchange soon. Huaheng Biotech proposes to raised funds of USD86.9 million (RMB570 million) for investment of two projects and supplementary working capital.

Published on 20th April, 2021

Meihua Group recorded revenues of USD2,599.7 million (RMB17,050 million) in 2020, up 17.2% YoY and net profits of USD149.7 million (RMB982.1 million), edging down by 0.7% over the last year. At the same time, its production base in Tongliao has been cut production due to Inner Mongolia's double control policy in 2021.

CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement